semaglutide hepatitis Wegovy Gets Green Light for Fatty Liver Disease Wegovy Treated Severe Liver Disease

One study found that 77% of PCOS patients lost more than 5% of their total body weight, and 55% achieved weight loss exceeding 10%

S2CID 19722541

Currently, no clinically significant changes in the absorption or action of co-administered oral medications have been reported, but patients with impaired kidney function taking medications that require weight-based dosing warrant more frequent monitoring

It is important to keep in mind that people taking GLP-1 medications may already be at risk of developing SIBO for other reasons

Neurological impact of vitamin B12 deficiency

Tell your provider if you are pregnant, plan to become pregnant, or are breastfeeding